We have provisionally termed this new subtype “De novo replication repair deficient glioblastoma, IDH-wildtype”, onto which “arising in the setting of genetically confirmed (or clinically diagnosed) Lynch syndrome” could be added to this integrated diagnosis as appropriate. The gene discussed is IDH1; the disease is Lynch syndrome.